Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
MQV
Very Strong
GARP
Very Strong
MQV Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Very Strong
Dividends
Very Strong
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Website
N/ATelephone
61.3.9087.1598
Address
Level 4 100 Albert Road South Melbourne, Victoria (VIC) 3205
Description
Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. It manages the provision of diagnostics goods and services. It operates through the United States and Australia geographical segments. The company was founded in 2015 and is headquartered in South Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.03 - 0.12
Trade Value (12mth)
AU$111,096.00
1 week
2.22%
1 month
12.2%
YTD
-38.67%
1 year
-50.54%
All time high
1.39
EPS 3 yr Growth
-77.30%
EBITDA Margin
-45.00%
Operating Cashflow
$1m
Free Cash Flow Return
6.10%
ROIC
-55.60%
Interest Coverage
-4.90
Quick Ratio
0.70
Shares on Issue (Fully Dilluted)
481m
HALO Sector
Healthcare
Next Company Report Date
26-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
06 September 24 |
Lumos Successfully Completes Institutional Entitlement Offer
×
Lumos Successfully Completes Institutional Entitlement Offer |
04 September 24 |
Trading Halt
×
Trading Halt |
04 September 24 |
Lumos Announces $10m Equity Raising and Welcomes Tenmile
×
Lumos Announces $10m Equity Raising and Welcomes Tenmile |
04 September 24 |
Investor Presentation
×
Investor Presentation |
04 September 24 |
Entitlement Offer Cleansing Notice
×
Entitlement Offer Cleansing Notice |
04 September 24 |
Proposed issue of securities - LDX
×
Proposed issue of securities - LDX |
04 September 24 |
Proposed issue of securities - LDX
×
Proposed issue of securities - LDX |
04 September 24 |
Ceasing to be a substantial holder
×
Ceasing to be a substantial holder |
04 September 24 |
Becoming a substantial holder
×
Becoming a substantial holder |
03 September 24 |
Lumos Announces Intention to Undertake Entitlement Offer
×
Lumos Announces Intention to Undertake Entitlement Offer |
27 August 24 |
FY24 Appendix 4E
×
FY24 Appendix 4E |
27 August 24 |
FY24 Annual Report
×
FY24 Annual Report |
27 August 24 |
FY24 Full Year Results Announcement
×
FY24 Full Year Results Announcement |
27 August 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
26 August 24 |
Lumos and BDI Progress New Point of Care Test
×
Lumos and BDI Progress New Point of Care Test |
05 August 24 |
Lumos Receives Research & Development Tax Rebate
×
Lumos Receives Research & Development Tax Rebate |
01 August 24 |
Q4 FY24 Investor Presentation
×
Q4 FY24 Investor Presentation |
31 July 24 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
29 July 24 |
Q4 FY24 Results Investor Briefing Invitation
×
Q4 FY24 Results Investor Briefing Invitation |
11 July 24 |
Notification of cessation of securities - LDX
×
Notification of cessation of securities - LDX |
09 July 24 |
Lumos Expands Henry Schein FebriDx Distribution Partnership
×
Lumos Expands Henry Schein FebriDx Distribution Partnership |
04 July 24 |
Lumos Expands Distribution for FebriDx in AUS and NZ
×
Lumos Expands Distribution for FebriDx in AUS and NZ |
19 June 24 |
Lumos Receives US$400k Phase 1 Milestone from Hologic
×
Lumos Receives US$400k Phase 1 Milestone from Hologic |
13 June 24 |
Change of Director's Interest Notice - SL
×
Change of Director's Interest Notice - SL |
13 June 24 |
Change of Director's Interest Notice - CR
×
Change of Director's Interest Notice - CR |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.